Methadone & Metabolite




Test Mnemonic

MMTAB

CPT Codes

  • 80358 - QTY (1)
  • G0480 - QTY (1)

LOINC ®

Not available

Aliases

  • Dolophine

Includes

  • Methadone
  • EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine)

Performing Laboratory

ARUP

FDA Category

Laboratory Developed Test


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLPlasmaPotassium oxalate/sodium fluoride (Gray) RefrigeratedSeparate plasma from cells ASAP or within 2 hours of collection and transfer into standard aliquot tube.

Alternate Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLSerumNo additive (Red) RefrigeratedDo not use serum separator tubes. Separate serum from cells ASAP or within 2 hours of collection and transfer into standard aliquot tube.
1 mLPlasmaSodium heparin (Green) RefrigeratedDo not use plasma separator tubes. Separate plasma from cells ASAP or within 2 hours of collection and transfer into standard aliquot tube.
1 mLPlasmaEDTA (Lavender) RefrigeratedSeparate plasma from cells ASAP or within 2 hours of collection and transfer into standard aliquot tube.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
0.5 mL     

Stability

Environmental Condition Description
AmbientAfter separation from cells: 1 week
RefrigeratedAfter separation from cells: 2 weeks
FrozenAfter separation from cells: 3 years (Avoid repeated freeze/thaw cycles)

Days Performed

Sun - Sat

Turnaround Time

2 - 8 days

Methodology

Name Description
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) 

Reference Range

Methadone
Sex Age From Age To Type Range Range Unit
       cutoff: 10 ng/mL 
Methadone Metabolite
Sex Age From Age To Type Range Range Unit
       cutoff: 10 ng/mL 

Special Info

Separator tubes, plasma or whole blood collected in sodium citrate (light blue) tubes, specimens exposed to repeated freeze/thaw cycles, and hemolyzed specimens will be rejected. This test is a reflex from Drug Screen 9 Panel, Serum or Plasma (DRGSC9). This test is New York DOH approved.

Clinical Info

Used to monitor patient adherence. The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive.

Clinical Limitation

For medical purposes only; not valid for forensic use.